November 21, 2020

US approves Regeneron antibody treatment given to Trump

Washington (AFP) – A Covid-19 antibody therapy used to treat President Donald Trump was approved by the US drug regulator on Saturday for people who aren’t yet hospitalized by the disease but are at high risk.The green light for drugmaker Regeneron came after REGEN-COV2, a combination of two lab-made antibodies, was shown to reduce Covid-19-related hospitalizations or emergency room visits in patients with underlying conditions.”Authorizing these monoclonal antibody therapies may help outpatients avoid hospitalization and alleviate the burden on our health care system,” said Stephen Hahn, comm…

source https://this.kiji.is/en/703073525637481569?c=648607265489716321

Leave a Reply

Your email address will not be published. Required fields are marked *